Top 36 Stocks by Pharmaceutical Products industry Cash & Equivalents

Assets	Cash	Buy And Hold Score	P/E	P/BV	Dividend yield	Average DY 5 years	Net Profit Margins	Sector	ROE	Current Price	Graham's Fair Value	Graham Upside	Profit	Revenue	Revenue Growth 5 years	Profit Growth 5 years	Return 30d	Return 12m	Market Cap	Net Worth
#161 LLY Eli Lilly and Compay	8.95 B	80	42.13	33.21	0.53%	1.24%	33.53%	Health	78.84%	$1,241.06	$159.88	-87.28%	7.10 B	22.97 B	22.98%	36.77%	10.38%	57.58%	1.13 T	33.88 B
#192 SNY Sanofi	7.32 B	100	3.78	0.70	4.38%	4.62%	14.25%	Health	18.43%	$39.59	$118.00	190.56%	2.25 B	25.47 B	18.22%	15.29%	-4.76%	-16.61%	55.83 B	80.15 B
#254 ONC BeiGene, Ltd.	5.10 B	50	35.68	8.27	0.00%	0.00%	19.58%	Health	23.19%	$370.17	$102.05	-72.35%	464.36 M	1.71 B	39.12%	-	5.98%	16.64%	42.81 B	5.17 B
#295 GSK GlaxoSmithKline PLC	4.14 B	80	15.38	4.34	3.58%	7.52%	14.54%	Health	28.24%	$49.46	$28.75	-41.92%	580.00 M	11.21 B	3.75%	2.87%	-0.05%	16.64%	99.47 B	22.90 B
#606 VTRS Viatris Inc.	1.51 B	30	-52.22	1.50	2.60%	1.99%	-2.79%	Health	-2.88%	$18.39	$6.54	-100.00%	-118.80 M	3.76 B	-3.80%	-20.20%	8.54%	89.94%	21.45 B	14.26 B

Ranking of Highest Cash & Equivalents Stocks of companies pharmaceutical products industry